Fine-needle aspiration cytology of thyroid nodules: Molecular diagnostics in a routine diagnostic setting;Feinnadelzytologie von Schilddrüsenknoten: Molekulare Diagnostik in der klinischen Routine

Deutsche Medizinische Wochenschrift

Volumn 139, Issue 10, 2014, Pages 476-480

  Eszlinger, M ^a,k   Neustadt, M ^a,k   Ruschenburg, I ^b   Neumann, A ^c   Franzius, C ^d   Adam, S ^e   Bacher, K ^f   Hach, A ^g   Hammoser, R ^h   Langvogt, C ⁱ   Molwitz, T ^j   Paschke, R ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Reproduktionsmedizin Zytologie Pathologie U Innere Medizin GmbH   (Germany)

^c Mikrobiologie U Genetik GmbH   (Germany)

^d Zentrum für Nuklearmedizin und PET CT Bremen im St Joseph Stift   (Germany)

^e Radiologie Hoheluft   (Germany)

^f Endokrinologie und Diabetologie im Zentrum   (Germany)

^g Institut für Radiologie and Nuklearmedizin   (Germany)

^h Schilddrüsenpraxis Kantstrae   (Germany)

ⁱ DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^j Klinik Dr Hancken   (Germany)

^k Gleichberechtigte Erstautoren ^*  (Germany)

more..

Author keywords

BRAF mutation; fine needle asipration cytology; molecular analysis; rearrangements; thyroid nodules

Indexed keywords

B RAF KINASE; DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; RAS PROTEIN; RNA; TRANSCRIPTION FACTOR PAX8;

ARTICLE; CYTODIAGNOSIS; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR DIAGNOSTICS; PAPILLARY CARCINOMA; POINT MUTATION; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; THYROID NODULE;

ADENOCARCINOMA, FOLLICULAR; ADENOCARCINOMA, PAPILLARY; BIOPSY, FINE-NEEDLE; CELL TRANSFORMATION, NEOPLASTIC; DIAGNOSIS, DIFFERENTIAL; GENE REARRANGEMENT; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; POINT MUTATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS B-RAF; RETROSPECTIVE STUDIES; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE;

EID: 84896864712     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0034-1369883     Document Type: Article

References (28)

1. Armstrong M., Yang H., Yip L. et al. The PAX8/PPARG mutation found in FNA predicts encapsulated follicular variant papillary thyroid caricinoma, not follicular carcinoma. American Thyroid Association Annual Meeting: 2013
2. Cantara S., Capezzone M., Marchisotta S. et al. Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. J Clin Endocrinol Metab: 2010; 95 1365 1369
3. Cibas E. S., Ali S. Z. The Bethesda System For Reporting Thyroid Cytopathology. Am J Clin Pathol: 2009; 132 658 665
4. Eszlinger M., Hegedus L., Paschke R. Ruling in or ruling out thyroid malignancy by molecular diagnostics of thyroid nodules. Best Practice Res Clin Endocrinol Metab: 2014; http://dx.doi.org/10.1016/j.beem.2014.01.011
5. Eszlinger M., Krane J. F., Cibas E. S., Paschke R. Molecular analysis of residual ThinPrep material after cytology classification according to the Bethesda System for Reporting Thyroid Cytopathology (TBS) increases sensitivity and allows molecular diagnostics for non-diagnostic samples. 83rd Annual Meeting of the American Thyroid Association: 2013
6. Eszlinger M., Krogdahl A., Munz S. et al. Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules. Thyroid: 2013; http://dx.doi.org/10.1089/ thy.2013.0278
7. Eszlinger M., Paschke R. Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns. Mol Cell Endocrinol: 2010; 322 29 37
8. Eszlinger M., Ruschenburg I., Paschke R. [Dignity of thyroid nodules: diagnostic gain by molecular fine needle aspiration cytology]. Dtsch Med Wochenschr: 2013; 138 2003 2006
9. Ferraz C., Eszlinger M., Paschke R. Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules. J Clin Endocrinol Metab: 2011; 96 2016 2026
10. Ferraz C., Rehfeld C., Krogdahl A. et al. Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears. Thyroid: 2012; 22 1025 1030
11. Gharib H., Papini E., Paschke R. et al. American Association of Clinical Endocrinologists, Italian Association of Clinical Endocrinologists and European Thyroid Association Medical Guidelines For Clinical Practice For the Diagnosis and Management of Thyroid Nodules. Endocr Pract: 2010; 16 01 1 43
12. Howell G. M., Hodak S. P., Yip L. RAS mutations in thyroid cancer. Oncologist: 2013; 18 926 932
13. Kim C. S., Zhu X. Lessons from mouse models of thyroid cancer. Thyroid: 2009; 19 1317 1331
14. Kondo T., Ezzat S., Asa S. L. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer: 2006; 6 292 306
15. Lang W., Georgii A., Stauch G. et al. The differentiation of atypical adenomas and encapsulated follicular carcinomas in the thyroid gland. Virchows Arch A Pathol Anat Histol: 1980; 385 125 141
16. Löwhagen T., Linsk J. A. Aspiration biopsy cytology of the thyroid gland. In: Linsk J. A., Franzen S. S. eds. Clinical Aspiration Cytology. Philadelphia Lippincott Williams and Wilkins: 1989
17. Nikiforov Y. E., Ohori N. P., Hodak S. P. et al. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab: 2011; 96 11 3390 3397
18. Nikiforov Y. E., Steward D. L., Robinson-Smith T. M. et al. Molecular testing for mutations in improving the fine needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab: 2009; 94 2092 2098
19. Nikiforova M. N., Biddinger P. W., Caudill C. M. et al. PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses. Am J Surg Pathol: 2002; 26 1016 1023
20. Nikiforova M. N., Lynch R. A., Biddinger P. W. et al. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab: 2003; 88 2318 2326
21. Paschke R., Schmid K. W., Gartner R. et al. [Epidemiology, pathophysiology, guideline-adjusted diagnostics, and treatment of thyroid nodules]. Med Klin: 2010; 105 80 87
22. Paschke R. Dignitätsbeurteilung von Schilddrüsenknoten: Diagnostischer Zugewinn durch molekulare Feinnadelaspirationszytologie. Dtsch Med Wochenschr: 2009; 134 2498 2503
23. Paschke R. [Drowning in a sea of thyroid nodules? Prevention and selection which nodules should undergo fine needle aspiration biopsy]. MMW Fortschr Med: 2010; 152 41 44
24. Piana S., Frasoldati A., Ferrari M. et al. Is a five-category reporting scheme for thyroid fine needle aspiration cytology accurate? Cytopathology: 2010; 22 164 173
25. Rehfeld C., Munz S., Krogdahl A. et al. Impact of different methodologies on the detection of point mutations in routine air-dried fine needle aspiration (FNA) smears. Horm Metab Res: 2013; 45 513 517
26. Vasko V., Ferrand M., Di Cristofaro J. et al. Specific pattern of RAS oncogene mutations in follicular thyroid tumors. J Clin Endocrinol Metab: 2003; 88 2745 2752
27. Volzke H., Ludemann J., Robinson D. M. et al. The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area. Thyroid: 2003; 13 803 810
28. Yip L., Farris C., Kabaker A. S. et al. Cost impact of molecular testing for indeterminate thyroid nodule fine-needle aspiration biopsies. J Clin Endocrinol Metab: 2012; 97 1905 1912